z-logo
open-access-imgOpen Access
Primary Isoniazid Prophylaxis against Tuberculosis in HIV-Exposed Children
Author(s) -
Shabir A. Madhi,
Sharon Nachman,
Avy Violari,
Soyeon Kim,
Mark F. Cotton,
Raziya Bobat,
Patrick JeanPhilippe,
George McSherry,
Charles D. Mitchell
Publication year - 2011
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1011214
Subject(s) - medicine , isoniazid , tuberculosis , chemoprophylaxis , human immunodeficiency virus (hiv) , pediatrics , placebo , randomized controlled trial , virology , immunology , pathology , alternative medicine
The dual epidemic of human immunodeficiency virus (HIV) and tuberculosis is a major cause of sickness and death in sub-Saharan Africa. We conducted a double-blind, randomized, placebo-controlled trial of preexposure isoniazid prophylaxis against tuberculosis in HIV-infected children and uninfected children exposed to HIV during the perinatal period.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom